CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

2 hedge funds and large institutions have $474K invested in CTI BioPharma Corp. (DE) Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 131 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 131

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1 -$52.2M
2 -$37.6M
3 -$37M
4
BlackRock
BlackRock
New York
-$29.8M
5
SCM
Stonepine Capital Management
Oregon
-$27.4M